// App-Quantinova.ai

TCT-137 : No benefit of Clopidogrel Pretreatment in stable patients undergoing elective PCI

Researchers

Presenter

  • Anne Bellemain-Appaix

Principal Investigators

  • Stephen A. -Connor

  • JOHANNE SILVAIN

  • Michel Cucherat

  • Jean-Philippe Collet

  • Francois Bernasconi

  • Gilles Montalescot

Medical Centers

  • Chu Lyon, Lyon, MS

  • CNAM, Paris, France

  • Salpetriere Hospital, Paris, France

  • CH La Fontonne Antibes, Antibes, France

  • pitie salpetriere, paris, France

  • CH La Fontonne Antibes, Antibes, France

  • pitie salpetriere, paris, France

Locations

  • United States

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Venous thrombosis

  • Stable coronary artery disease

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved